BIBW 2992 (Afatinib), EGFR and HER2 inhibitor (TBI4510)

Description

Product Details

Formal Name: N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4(dimethylamino)-2E-butenamide

Alternate Names: BIBW2992

Molecular Formula: C₂₄H₂₅ClFN₅O₃

Formula Weight: 485.94

CAS Number: 439081-18-2

Purity: >97%

Formulation: powder

Solubility: Soluble in DMSO (up to 25 mg/ml) or in Ethanol (up to 25 mg/ml).

Storage: -20°C

Stability: ≥ 1 year.

 

Applications

EGFR and HER2 inhibitor

 

Functions

Afatinib is a clinically useful kinase inhibitor approved for the treatment of non-small cell lung cancer. It is a potent and highly selective inhibitor of mutant and wild-type EGFR (IC50 = 0.5 nM) and HER2 (IC50 = 14 nM).

 

Application Procedures

First dissolved in DMSO (up to 25 mg/ml) or in Ethanol (up to 25 mg/ml), then diluted to aqueous buffer. Solutions in DMSO or Ethanol may be stored at -20°C for up to 2 months.

Additional information

SIZE (mg)	10 MG, 50 MG

TBI4510_BIBW 2992 (Afatinib)